baber/WOPTO huggingface dataset:
Patent CY-1122371-T1 (CY)
Title: Συνολο υποστηριγματος μονταρισματος
Inventor: WILLIAMSON JOHN N
IPC: H02S20/10
Filed: 2019-11-11
Abstract: Ένα σύνολο υποστηρίγματος μονταρίσματος αποτελείται από ένα εύκαμπτο σώμα που συμπεριλαμβάνει τουλάχιστον ένα μέλος κορυφής και ένα εύκαμπτο γωνιώδες μέλος πυθμένα που συνδέεται στο μέλος κορυφής. Το εύκαμπτο σώμα ορίζει μία οπή εισαγωγής δοκού μεταξύ του μέλους κορυφής και του μέλους πυθμένα. Το σύνολο υποστηρίγματος μονταρίσματος περαιτέρω αποτελείται από τουλάχιστον έναν σφιγκτήρα συνδεδεμένο στο μέλος κορυφής. Το σύνολο υποστηρίγματος μονταρίσματος μπορεί περαιτέρω να αποτελείται από μία σπειρωτή ράβδο που διατρέχει το τουλάχιστον ένα μέλος κορυφής και ένα περικόχλιο σύσφιγξης που ασφαλίζει τη σπειρωτή ράβδο στο μέλος κορυφής έτσι ώστε περιστροφή του περικοχλίου σύσφιγξης συμπιέζει το μέλος κορυφής και γειώνει μία συσκευή παραγωγής ηλεκτρισμού όπως για παράδειγμα μία φωτοβολταϊκή μονάδα. Το σύνολο υποστηρίγματος μονταρίσματος μπορεί περαιτέρω να αποτελείται από μία ακέραιη συσκευή γείωσης που διατάσσεται παρακείμενη στο μέλος κορυφής για ηλεκτρική γείωση της συσκευής παραγωγής ηλεκτρισμού.
Patent CY-1122543-T1 (CY)
Title: Δεσμευοντα μορια για bcma και cd3
Inventor: KUFER PETER
IPC: C07K16/28
Filed: 2019-11-13
Abstract: Η παρούσα εφεύρεση σχετίζεται με δεσμεύον μόριο το οποίο είναι τουλάχιστον διπλοειδικό, που περιλαμβάνει πρώτη και δεύτερη επικράτεια δέσμευσης, όπου η πρώτη επικράτεια δέσμευσης είναι ικανή να δεσμευθεί στη επιτοποσυστάδα 3 του BCMA, και η δεύτερη δεσμεύουσα επικράτεια είναι ικανή να δεσμευθεί στο σύμπλεγμα CD3 υποδοχέα Τ κυττάρου. Επιπλέον, η εφεύρεση παρέχει αλληλουχία νουκλεϊκού οξέος που κωδικεύει το δεσμεύον μόριο, κομιστή που περιλαμβάνει την εν λόγω αλληλουχία νουκλεϊκού οξέος και κύτταρο-ξενιστή μετασχηματισμένο ή επιμολυσμένο με τον εν λόγω κομιστή. Περαιτέρω, η εφεύρεση παρέχει διεργασία για την παραγωγή του δεσμεύοντος μορίου της εφεύρεσης, ιατρική χρήση του εν λόγω δεσμεύοντος μορίου και κιτ που περιλαμβάνει το εν λόγω δεσμεύον μόριο.
Patent CY-1123561-T1 (CY)
Title: Ενωσεις χρησιμες ως αναστολεις κινασης
Inventor: GUISOT NICOLAS
IPC: C07D405/14
Filed: 2020-11-16
Abstract: Η εφεύρεση αυτή αφορά σε νέες ενώσεις. Οι ενώσεις της εφεύρεσης είναι αναστολείς κινάσης τυροσίνης. Ειδικότερα, οι ενώσεις της εφεύρεσης είναι χρήσιμες ως αναστολείς κινάσης τυροσίνης Bruton (ΒΤΚ). Η εφεύρεση εξετάζει επίσης τη χρήση των ενώσεων για θεραπεία καταστάσεων που μπορεί να θεραπευτούν με την αναστολή κινάσης τυροσίνης Bruton, για παράδειγμα καρκίνο, λέμφωμα, λευχαιμία και ανοσολογικές ασθένειες.
Patent HR-P20110709-T1 (HR)
Inventor: MOUSSY ALAIN
IPC: C07D417/04
Filed: 2011-10-05
Abstract: Postupak proizvodnje spoja formule I: Ili soli ili njegova rastvora, pri čemu su R1 i R2 nezavisno odabrani od vodika, halogena ili opcionalno supstituiranog linearnog ili razgranatog alkila, opcionalno supstituirane cikloalkilne skupine s jednim do deset atoma ugljika, trifluorometila, opcionalno supstituirane alkoksilne, cijanske, dialkilaminske i rastvorne skupine, m je 0 - 5, a n je 0 - 4, pri čemu se rastvorna skupina odabire iz sljedećeg: - 	alkilne skupine supstituirane jednim ili više heteroatoma, kao što su N, O, S, koji se svaki opcionalno supstituira alkilnom skupinom nezavisno supstituiranom alkoksilnom, aminskom, alkilaminskom, dialkilaminskom, karboksilnom, cijanskom ili supstituiranom cikloheteroalkilnom, heteroarilnom, fosfatnom, sulfatnom ili karboksilnom kiselinom- 	alkilne, cikloalkilne, arilne, heteroarilne skupine koja se sastoji od najmanje jednog heteroatoma dušika ili kisika ili je supstituirana najmanje jednom aminskom ili okso-skupinom- 	aminske skupine koja može biti zasićena ciklaminska skupina, koja može biti supstituirana skupinom koja se sastoji od alkila, alkoksikarbonila, halogena, haloalkila, hidroaksialkila, amina, monoalkilamina, dialkilamina, karbamoila, monoalkilkarbamoila i dialkilkarbamoila- 	jedne od struktura od a) do i) prikazanih u nastavku, pri čemu valovita crta i crta sa strelicom odgovaraju točki spajanja s osnovnom strukturom formule I: R3 je jedno od sljedećeg: (i)	arilna skupina, kao što je fenil ili njegova supstituirana varijanta koja na bilo kojem prstenu ima bilo koju kombinaciju jednog ili više supstituenata, kao što su halogen, alkilne skupine s jednim do deset atoma ugljika, trifluorometil, cijanska i alkoksilna skupina (ii)	heteroarilna skupina, kao što je 2, 3 ili 4-piridilna skupina, koja može imati i bilo koju kombinaciju jednog ili više supstituenata, kao što su halogen, alkilne skupine s jednim do deset atoma ugljika, trifluorometilna i alkoksilna skupina (iii)	aromatska heterociklična skupina petočlanog prstena, npr. 2-tienil, 3-tienil, 2-tiazolil, 4-tiazolil, 5-tiazolil, koja može imati i bilo koju kombinaciju jednog ili više supstituenata, kao što su halogen, alkilna skupina s jednim do deset atoma ugljika, trifluorometilna i alkoksilna skupina, a čini korake koji se sastoje od sljedećeg: a)	ciklizacije spoja sljedeće formule (IV) pri sobnoj temperaturi: uz intermedijer (Int4) sljedeće formule: Int4pri čemu Ra može biti opcionalno supstituiran metil, trifluorometil, izopropil ili fenil, dok su R2, R3 i n prema gornjem opisu, čime se stvara spoj formule (III): u kojem su R2, R3 i n gore opisani spojevib)	redukcije dušične skupine navedenog spoja formule (III) radi stvaranja spoja formule (II): u kojem su R2, R3 i n gore opisani spojevic)	sprega spoja formule (II) u aprotičnom otapalu: sa spojem formule Int5(Int5) pri čemu je Rb hidroksilna, alkoksilna ili halogena skupina, a R1 i m spojevi opisani su gore. Procesom se stvara spoj formule (I). Patent sadrži još 24 patentna zahtjeva.
Patent SI-1654387-T1 (SI)
Title: Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
Inventor: EWERT MATT
IPC: C12Q1/68
Filed: 2004-08-16
Abstract: The present invention provides a method of nucleic acid extraction, comprising contacting a blood sample with a composition comprising aurintricarboxylic acid, a DNase and an enzyme that will break down a nuclear membrane.
Patent SI-1736194-T1 (SI)
Title: Implantable medical device with indicator for movable retention members
Inventor: HUNT JOHN V
IPC: A61M39/00
Filed: 2006-06-23
Abstract: An attachment mechanism for a surgically implantable medical device includes one or more fasteners which may be simultaneously moved from an undeployed position to a deployed position by operation of an integral actuator. The attachment mechanism may be configured to be deactuated, and the fasteners simultaneously moved from a deployed position to an undeployed position, allowing removal or repositioning of the medical device. An applier includes a locator for detachably holding the implantable medical device, locating it at the desired position, and actuating the attachment mechanism. The applier is configured to undeploy the attachment mechanism the implantable medical device can be detached from the body tissue.
Patent SI-2158689-T1 (SI)
Title: Scrambling methods for synchronization channels
Inventor: LUO TAO
IPC: H04B1/707
Filed: 2008-05-21
Abstract: Systems and methods are provided that facilitate generation and detection of synchronization channels in a wireless communication system. A one-to-one relationship is established among a set of scrambling codes (SCs) and a set of primary synchronization channel (P-SCH) sequences which are determined by a reusable sector identifier that is determined through detection of the P-SCH channel. The set of scrambling codes are utilized to (i) scramble a secondary synchronization channel sequence which facilitates detection of the S-SCH sequence once the reusable sector identifier is detected, or (ii) compose an unscrambled S-SCH sequence through a sequential or interleaved concatenation of SCs wherein a concatenation indication is received in a mobile terminal. Cyclic shifts and sign-flip operations applied to a base sequence are employed to generate SCs. A lookup table and a library of SCs facilitate scrambling code determination in a mobile terminal that receives associated P-SCH and S-SCH sequences.
Patent SI-2706982-T1 (SI)
Title: Intranasal pharmaceutical dosage forms comprising naloxone
Inventor: STRANG JOHN
IPC: A61P25/00
Filed: 2012-05-11
Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to = 0.5 mg naloxone HCl dissolved in an application fluid of a volume of = 250 µl. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
Patent SI-2758388-T1 (SI)
Title: New bicyclic dihydroquinoline-2-one derivatives
Inventor: AEBI JOHANNES
IPC: C07D471/00
Filed: 2012-09-20
Abstract: The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, A1, A2 A3 and n are as described herein, compositions including the compounds and methods of using the compounds. The compounds of the present invention are useful as inhibitors of aldosterone synthase. The compounds may be used, for example, in the treatment or prophylaxis of chronic kidney disease, congestive heart failure, hypertension, primary aldosteronism and Cushing syndrome.
Patent TR-200001659-T1 (TR)
Inventor: BLEIKOLM ANTON
IPC: C09D11/00
Filed: 1999-10-08
Abstract: An ink composition containing at least two different types of optically variable pigments which produce a film or coating having a viewing angle dependent color shift.
Patent DE-3486238-T2 (DE)
Inventor: RIVIER JEAN E F
IPC: A61K38/02
Filed: 1984-04-13
Granted: 1994-03-03
Abstract: Rat Corticotropin Releasing Factor (rCRF) and the human counterpart thereof have the formula:
 H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-
 Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-
 Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-
 Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2.
 Analogs are disclosed that are at least as potent. One which has been found to be particularly potent is:
 H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-
 Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-
 Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-
 Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2.
 These analogs or pharmaceutically or veterinarily acceptable salts thereof, dispersed in a pharmaceutically or veterinarily acceptable liquid or solid carrier, can be administered to mammals, including humans, to achieve a substantial elevation of ACTH,  beta -endorphin,  beta -lipotropin, other products of the pro-opiomelanocortin gene and corticosterone levels and/or a lowering of blood pressure over an extended period of time. They may also be used as stimulants to elevate mood and improve memory and learning, as well as diagnostically. 
<??>In the analogs, one or more of the first three N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long and/or by an acylating agent containing up to 7 carbon atoms. A number of other substitutions may also be made throughout the chain.
Patent DE-3751826-T2 (DE)
Inventor: PASULA MARK J
IPC: A61B5/145
Filed: 1987-08-24
Granted: 1997-01-23
Abstract: A method for the diagnosis of a malady in a subject by observing a degree of reaction between all blood cells: red blood cells, leukocytes and platelets; in the subject's blood with a foreign entity having a predetermined relationship with the malady being diagnosed. The test includes comparing amounts and sizes of red blood cells, leukocytes and/or platelets in a control sample and at least one test sample. The test sample includes a portion of the subject's blood and the foreign entity being tested.
Patent DE-3878577-T2 (DE)
Inventor: BARRITAULT DENIS STEPHAN CHARL
IPC: A61K35/30
Filed: 1988-04-14
Granted: 1993-07-01
Abstract: The invention relates to the use, as a stationary phase in affinity chromatography in the purification of growth factors of the FGF type, of polymers or copolymers to which are bound, in statistical fashion, -SO3H groups and groups -SO3M where M represents a physiologically acceptable metal, as well as, preferably, groups -SO2R where R represents a radical obtained by removal of a hydrogen atom on the amine function of an amino acid or an amino acid derivative. The invention also relates to the production of a purified bFGF or aFGF growth factor, or of a mixture of these growth factors, which consists in performing affinity chromatography on a resin as defined above, an elution being carried out with a buffer of neutral pH having an ionic strength equivalent to that of a 0.15M to 2.5M NaCl solution.
Patent DE-3879606-T2 (DE)
Inventor: YOUNG RONALD ALEXANDER
IPC: A47L13/58
Filed: 1988-10-05
Granted: 1993-10-28
Abstract: Cleaning equipment comprises a container 1 from which cleaning liquid 2 is taken, and to which the liquid is returned after it has been used for dirt removal. The container 1 is provided with a dirt trap comprising a dirt-receiving element 3 of mat or pad-like form which is positioned in the container 1 to receive dirt settling under gravity from the contained liquid 2. The dirt which settles out collects in, or alternatively passes through so as to be trapped below, the element 3. The form and structure of the element 3 is such that disturbance of the liquid 2 in the container 1 cannot wash the collected dirt back out into the main body of liquid 2 from, or through, the element 3 to any significant extent.
Patent DE-3887295-T2 (DE)
Inventor: NODDIN RICHARD A
IPC: A61M25/00
Filed: 1988-11-29
Granted: 1994-06-30
Abstract: An inflatable medical balloon is formed by fabricating a tubular preform having a tapered region at the end of the portion where the main body of the balloon will form to enable the corresponding transition section of the blown balloon to have a separately controllable thickness profile. The preferred method includes providing a tube of a selected resin of wall thickness and diameter suitable for being formed into a balloon, and selectively heating to drawing temperature a defined region of the tube at one or both ends of the portion of the tube from which the balloon is to be formed. Tension is applied in opposite directions to respective ends of the heated region to draw the region to a smaller diameter, thereby providing a preform having, at the end of the portion of the tube, a tapered, relatively small diameter region of material that has substantially no crystallization or molecular orientation. In preferred embodiments a tapered region is provided at both ends of the portion in which the main body of the balloon is to be formed. Thereafter the tubular preform is heated to blowing temperature and, while heated, a balloon is formed by drawing and blowing the preform including the tapered regions. The balloon is mounted to form a balloon catheter device. A dilatation balloon catheter, is also described having wall thickness in the transition region less than 0.001 inch.
Patent DE-60001349-T2 (DE)
Inventor: KALNES TOM N
IPC: C10G49/22
Filed: 2000-11-22
Granted: 2003-12-24
Abstract: A catalytic hydrocracking process wherein a hydrocarbonaceous feedstock is converted by combining with a hot recycle stream containing hydrogen, and the mixture is passed to a denitrification and desulfurization reaction zone, and then to a hydrocracking zone. The resulting hot, uncooled effluent from the hydrocracking zone is hydrogen stripped in a stripping zone maintained at essentially the same pressure as the hydrocracking zone to produce a vapor stream containing hydrogen, hydrocarbonaceous compounds boiling at a temperature below the boiling range of the fresh feedstock, hydrogen sulfide and ammonia, and a liquid hydrocarbonaceous stream wherein at least a portion of this liquid stream is then passed to the denitrification and desulfurization reaction zone. At least another portion of the liquid stream is admixed with the subsequently cooled vapor stream to produce a hydrogen-rich recycle gas stream and a liquid hydrocarbonaceous stream containing hydrocarbonaceous compounds boiling at a temperature below the boiling range of the fresh feedstock.
Patent DE-60011816-T2 (DE)
Inventor: PAUL L
IPC: A61F2/16
Filed: 2000-11-16
Granted: 2005-06-30
Abstract: There is provided an intraocular lens, comprising: an optic (110) sized and adapted for placement in the capsular bag of the eye and for directing light toward the retina of the eye, the optic having: a central optical axis (OA); a convex anterior face (AF) and a convex posterior face (PF) for focusing light rays striking the anterior face onto the retina of the eye; a peripheral edge (112) disposed between the anterior and posterior faces circumscribing the optic, at least part of the peripheral edge being roughened; and a peripheral edge corner (116) formed at an intersection at the peripheral edge and the convex posterior face, the peripheral edge corner being located at a visible discontinuity; and a plurality of fixation members integral with the optic, the intraocular lens consisting of one piece, with unitary optic and fixation members.
Patent DE-60013353-T2 (DE)
Inventor: WINTER BEAT
IPC: A61K8/33
Filed: 2000-05-04
Granted: 2005-09-08
Abstract: A compound of formula <CHEM> wherein either the dotted line indicates the location of a double bond, n is equal to 1 and R represents a hydrogen atom or a methyl radical, or the dotted line indicates the location of a single bond, n is equal to 0 and R represents a hydrogen atom, is useful as a perfuming ingredient for the preparation of perfuming compositions and perfumed products, to which it imparts odor notes of the lily of the valley type.
Patent DE-60016632-T2 (DE)
Inventor: BONNARD OLIVIER
IPC: A61F2/34
Filed: 2000-03-20
Granted: 2005-07-07
Abstract: The invention concerns a cup (1) for anchoring in the acetabular bone (2) designed to act as sliding surface for a shell (16) comprising several bone anchoring processes, in particular: an annular contact portion (3) whereof the embossed protuberances (4) produce compression perpendicular to the cylindro-spherical region (5) adjacent to the opening plane (6) of the acetabular bone through strips substantially parallel to said opening plane (6) and radial grooves oriented towards the support pole (7); a polar supporting portion (7) in the form of a sphere portion, oblique relative to said opening plane (6) and oriented perpendicular relative to the direction of the resultant (8) of muscular forces (81) and gravity (82); a series of counter rotating ribs (9) radially arranged; at least a fixing plate (11) radially arranged relative to the equator (61) designed to receive fixing means (11), at least a through an orifice (12) of said cup (1) and designed to receive a pin (14).
Patent DE-60019550-T2 (DE)
Inventor: REMON JEAN PAUL
IPC: A61K47/12
Filed: 2000-07-26
Granted: 2006-05-04
Abstract: Biologically inactive cushioning beads comprise at least one compressible cushioning component consisting essentially of a microcrystalline hydrocarbon wax or a natural wax, the said wax being at least 30% by weight of the biologically inactive cushioning beads. Such beads are useful for making solid shaped articles containing biologically active ingredients by compression.
Patent DE-60021416-T2 (DE)
Inventor: JONES JOHN CLIFFORD
IPC: G02F1/139
Filed: 2000-11-23
Granted: 2006-05-24
Abstract: A liquid crystal device comprises a layer (2) of a nematic liquid crystal material contained between two cell walls (3, 4) each carrying electrode structures (6, 7) and an alignment surface (20, 21). The alignment layer (20, 21) on one or both cell wall (4), is formed of a plurality of small (<15 μm) surface features each separably capable of providing a bistable pretilts and an alignment direction and collectively causing larger variations of molecular orientation across the layer (2). The device may be switched between a light transmissive state and a light non-transmissive state. The small surface features may be areas of grating (21), protrusions (25), or blind holes (26), separated by mono stable flat surfaces (Fm) coated with a homeotropic alignment layer. Preferably, the grating etc provides bistable switching operation between a low surface tilt and high surface tilt, and the low tilt alignment direction varies between adjacent grating areas.
Patent DE-60025632-T2 (DE)
Inventor: LUENGO I
IPC: C07D231/48
Filed: 2000-09-08
Granted: 2006-08-10
Abstract: Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
Patent DE-60026122-T2 (DE)
Inventor: AYAKO SHINDO
IPC: C03C10/12
Filed: 2000-12-06
Granted: 2006-09-21
Abstract: A glass ceramic comprises a main crystal phase which comprises at least one selected from a group consisting of  beta -eucryptite ( beta -Li2O.Al2O3.2SiO2),  beta -eucryptite solid solution ( beta -Li2O.Al2O3.2SiO2 solid solution),  beta -quartz ( beta -SiO2), and beta -quartz solid solution ( beta -SiO2 solid solution), wherein an average grain size of the main crystal phase is less than 5  mu m, and a coefficient of thermal expansion thereof is -30 x 10<-7> to -90 x 10<-7>/ DEG C in a temperature range of -40 DEG C to +160 DEG C, and a hysteresis of the coefficient of thermal expansion is not more than 20 ppm. <IMAGE>
Patent DE-60029293-T2 (DE)
Inventor: YANO KENTARO
IPC: C07D401/14
Filed: 2000-06-01
Granted: 2007-07-19
Abstract: The present invention provides organic compounds which improve the light resistance of organic dye compounds without substantially deteriorating their preferable light properties when applied to them, and have satisfactory solubility in organic solvents and compatibility with organic dye compounds. The object of the present invention is solved by formazan metal compounds which comprise specific formazan compounds as ligands; process thereof; light-resistant improvers, optical recording media, and light absorbents, which all comprise the formazan metal complexes; and formazan compounds as intermediates for producing the formazan metal complexes
Patent DE-60103596-T2 (DE)
Inventor: RECHBERGER ROBERT
IPC: G06K1/12
Filed: 2001-03-06
Granted: 2005-06-16
Abstract: A data carrier (2) includes memory (16) adapted to store the information data (ID), and further includes first detection unit (28) adapted to detect first command data (CD1), and further includes initialization unit adapted to initialize, after detection of the first command data (CD1), the memory (16) for the storage of information data (ID), and further includes a second detection unit (29) adapted to detect second command data (CD2), and further includes write unit (32) adapted to write the information (ID) into the initialized memory (16) after detection of the second command data (CD2).
Patent DE-60113999-T2 (DE)
Inventor: BOURGART FABRICE
IPC: H04Q7/20
Filed: 2001-06-13
Granted: 2006-06-22
Abstract: The invention provides a portable and autonomous assistance device to derive information on faults in a private telecommunication installation comprising particularly equipment units to assist the client owning the installation in maintaining the latter. A maintenance session is selected in a maintenance server of the service provider managing the installation as a function of information transmitted by the assistance device so as to provide instructions in the device. The address of the server and an identifier of the equipment unit are rapidly read by means of a bar code reader which can also read bar codes in a user manual. The assistance device also serves to configure a terminal (TE) by means of a configuration session opened in a server (SFT) of the terminal manufacturer.